Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Feb;29(2):261-7.
doi: 10.1161/ATVBAHA.108.178681. Epub 2008 Nov 13.

HDL remodeling during the acute phase response

Affiliations

HDL remodeling during the acute phase response

Anisa Jahangiri et al. Arterioscler Thromb Vasc Biol. 2009 Feb.

Abstract

Objective: The purpose of this study was to examine the interactive action of serum amyloid A (SAA), group IIA secretory phospholipase A(2) (sPLA(2)-IIA), and cholesteryl ester transfer protein (CETP) on HDL remodeling and cholesterol efflux during the acute phase (AP) response elicited in humans after cardiac surgery.

Methods and results: Plasma was collected from patients before (pre-AP), 24 hours after (AP-1 d), and 5 days after cardiac surgery (AP-5 d). SAA levels were increased 16-fold in AP-1 d samples. The activity of sPLA(2)-IIA was increased from 77.7+/-38.3 U/mL (pre-AP) to 281.4+/-57.1 U/mL (AP-1 d; P<0.001). CETP mass and activity reduction was commensurate to the reduction of HDL cholesterol levels. The combined action of SAA, sPLA(2)-IIA, and CETP in vitro markedly remodeled HDL with the generation of lipid-poor apoA-I from both pre-AP and AP-1 d HDL. The net result of this remodeling was a relative preservation of ABCA1- and ABCG1-dependent cholesterol efflux during the acute phase response.

Conclusions: Our results show that the many and complex changes in plasma proteins during the acute phase response markedly remodel HDL with functional implications, particularly the relative retention of cholesterol efflux capacity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
SAA (A) and sPLA2 (B) concentrations in pre-AP, AP- 1d and AP- 5d plasma. Data is presented as mean ± SEM. n=12 (SAA); n=6 (sPLA2); * p < 0.05 versus pre-AP by one way repeated measures ANOVA.
Figure 2
Figure 2
CETP, HDL cholesterol and apoA-I are reduced in AP- 1d plasma. (A) Plasma CETP concentrations were quantified by densitometric analysis of Western blots. (B) CETP activity (C) HDL-C concentrations and (D) apoA-I concentrations in pre-AP and AP- 1d plasma. ** p < 0.01, *** p < 0.001 by paired t-test.
Figure 3
Figure 3
Apolipoprotein characterization of pre-AP HDL, AP- 1d HDL and SAA-HDL. (A) SDS gel of HDL (5 μg total protein). (B) 125I-pre-AP HDL (5 μg) was passed through an anti-apoA-II immunoaffinity column and fractions were electrophoresed and autoradiographed as outlined in the methods (ARG). (C) 125I-AP HDL (10 μg) was passed through an anti-SAA immunoaffinity column with subsequent electrophoresis and ARG as described in (B). (D) 125I-AP HDL (10 μg) was passed through an anti-apoA-II immunoaffinity column with subsequent electrophoresis and ARG as described in (B). Note: the gels in B–D were loaded on the basis of 2000 cpm per lane and since the majority of counts were present in E1 and E2, E3–E5 quantitatively represent a smaller percentage of total protein mass.
Figure 4
Figure 4
Dissociation of lipid-poor apoA-I from pre-AP and AP- 1d HDL following remodeling by CETP. HDLs were incubated with CETP in the presence of VLDL for 24 hr at 37°C as outlined in the methods. Reactions were analyzed by Western blot for (A) apoA-I and (B) SAA. The migration of lipid-poor apoA-I and SAA are marked with arrows.
Figure 5
Figure 5
The combined action of sPLA2-IIA and CETP on HDL2 and SAA-HDL. HDL were incubated with sPLA2-IIA and CETP as set out in the methods. Reactions were analyzed by Western blot for apoA-I in (A) HDL2 and (B) SAA-HDL and (C) SAA blot of SAA-HDL.

Similar articles

Cited by

References

    1. Cabana VG, Siegel JN, Sabesin SM. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res. 1989;30:39–49. - PubMed
    1. Menschikowski M, Hagelgans A, Siegert G. Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases? Prostaglandins Other Lipid Mediat. 2006;79:1–33. - PubMed
    1. Coetzee GA, Strachan AF, van der Westhuyzen DR, Hoppe HC, Jeenah MS, de Beer FC. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J Biol Chem. 1986;261:9644–9651. - PubMed
    1. de Beer FC, de Beer MC, van der Westhuyzen DR, Castellani LW, Lusis AJ, Swanson ME, Grass DS. Secretory non-pancreatic phospholipase A2: influence on lipoprotein metabolism. J Lipid Res. 1997;38:2232–2239. - PubMed
    1. Barter PJ. Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors. Atheroscler Suppl. 2002;3:39–47. - PubMed

Publication types

MeSH terms